Abstract:Abstract Background/Introduction coronary revascularization in patients with de novo three-vessel coronary artery disease (3VD) without Left Main disease can be performed by either PCI or CABG after objective Heart Team consensus. In the ongoing Multivessel TALENT trial (NCT04390672)1, the intended multivessel PCI is performed using DES with ultrathin struts and biodegradable polymers under the guidance of quantitative flow ratio (QFR) and intracoronary imaging with IVUS or OCT. Purpose The Logistic Clinical SYNTAX score (logSYNTAX) to predict 2-year all-cause mortality after PCI was developed in 15,883 patients treated in the GLOBAL LEADERS trial and externally validated in 10,100 patients. This study aims to predict 2-year all-cause mortality after intended multivessel PCI in the currently enrolled trial population to identify patients who should be considered high risk. Methods and results We performed an interim analysis in the first consecutive 781 patients of the ongoing Multivessel TALENT Trial aimed to enrol 1550 patients. Thirteen clinical predictors are used in the logSYNTAX score: SYNTAX I-score, presence of 3VD and/or LM disease, age, creatinine clearance in mL/min, LVEF, BMI, serum hemoglobin level(g/dL), the White Blood Cell Count (WBC, in 109 cells/L) and the presence of COPD, PVD, diabetes mellitus, current smoking and/or a history of stroke. LVEF and BMI have additional squared terms to adjust for non-linear associations with all-cause mortality. The predicted mortality was estimated using the survival function developed in the GLOBAL LEADERS trial. We considered patients high-risk if the estimated risk was above the 3rd quartile. In 563 patients, all thirteen predictors necessary for 2-year mortality prediction were available. Median 2-year all-cause mortality of 1.9% (1.09-3.82; IQR2.73). 142 patients (25%) with an increased estimated 2-year mortality risk (>3.8%) due to higher prevalence of the aforementioned predictors; higher median age [75 (9.0) vs. 67 (12.0), p <0.001], a lower median LVEF [55% (20) vs. 94% (35.5), p <0.001] and a higher median SYNTAX score [26.0 (13.5) vs. 20.0(11.0), p <0.001]. A complete overview of predictors can be found in table 1. High age, an impaired LVEF, and an increased anatomical SYNTAX-I score were the main contributors to high mortality in this study cohort (see figure 1). Conclusion(s) In 563 patients, the median predicted 2-year all-cause mortality was 1.9%. Nevertheless, a non-neglectable amount of patients were estimated to be at increased risk for all-cause 2-year mortality. Accurate prediction by knowledge of aforementioned predictors is pivotal for appropriate mortality risk prediction to segregate high-risk patients with 3VD for individual decision-making on coronary revascularization, even if surgical revascularization is no option, and guide optimal treatment with use of intravascular imaging to achieve an optimal PCI result.Table 1Figure 1

Baseline Troponin-T is Powerful Predictor of Mortality after Coronary Bifurcation Stenting

Bifurcation Functional Significance Score As Predictor of Mortality: a Validating Study.

Bifurcation Functional Significance Score as Predictor of Mortality

Determinants of Functional Significance of Coronary Bifurcation Lesions and Clinical Outcomes after Physiology-Guided Treatment

Mid-Term Clinical Outcomes Of Functionally-Guided Treatment Of Coronary Bifurcation Lesions

Prediction Of Functional Severity Of Coronary Bifurcation Lesions By Means Of Angiographically-Derived Score

Side Branch Predilatation During Percutaneous Coronary Bifurcation Intervention: Long-term Mortality Analysis

Intracoronary Electrocardiography-guided Strategy for the Treatment of Coronary Bifurcation Lesions

Prediction of troponin elevation by means of intracoronary electrocardiogram during percutaneous coronary intervention of coronary bifurcation lesions (from COronary SIde Branch Residual IschemiA and COllateralization Assessment Study; COSIBRIA & Co Study.

Prognostic Impact of New-Onset Atrial Fibrillation after Single or Double Stent Left Main Bifurcation PCI

P429 PROGNOSTIC IMPACT OF ROUTINE SIX–MONTH EXERCISE STRESS TEST AFTER COMPLEX LEFT MAIN BIFURCATION PCI

Long-Term Outcomes of Left Main Bifurcation Double Stenting in Patients with STEMI and Cardiogenic Shock

Association of peri-procedural myocardial infarction with mortality after stenting true coronary bifurcation lesions: A pooled individual participant data analysis from four randomized controlled trials

Periprocedural Myocardial Infarction Is Associated With Increased Mortality In Patients With Coronary Artery Bifurcation Lesions After Implantation Of A Drug-Eluting Stent

Clinical prognostic value of a novel quantitative flow ratio from a single projection in patients with coronary bifurcation lesions treated with the provisional approach.

High-Risk Morphological and Physiological Coronary Disease Attributes As Outcome Markers after Medical Treatment and Revascularization.

Intracoronary Electrocardiogram to guide Percutaneous Interventions in Coronary Bifurcations: A proof of Concept: The FIESTA (Ffr vs. IcEcgSTA) study.

Interim prediction of two-year all-cause mortality in patients with de novo multivessel coronary artery disease undergoing intended multivessel PCI

Side Branch Long Lesion with Main Vessel Vulnerable Plaques by Optical Coherence Tomography Predict Target-Vessel Myocardial Infarction after Provisional Stenting in Patients with Coronary Bifurcation